Price : USD 397000.00 ~~794000.00~~

Quantity:

Description:

Ravicti is used to treat urea cycle disorders (UCD), genetic diseases that prevent the body from getting rid of ammonia. The resulting buildup of the toxic substance can lead to brain damage and death, so forgoing treatment is not an option. Horizon Pharma (NASDAQ:HZNP) sells Ravicti at an annual cost per patient of nearly $794,000.

There are an estimated 2,000 individuals in the U.S. who suffer from urea cycle disorders that could potentially be treated by Ravicti. Horizon's drug treats seven types of UCDs, though it's unknown whether Ravicti is safe and effective for treating an especially rare type known as N-acetylglutamate synthetase (NAGS) deficiency.

Terms & conditions:

Safety and Abuse Reporting

Harassment and Cyberbullying

Impersonation

Violent Threats

Hate Speech Against a Protected Group

Spam and Scams

None of these are my issue

Thanks for being awesome!

We appreciate you contacting us. Our support will get back in touch with you soon!

Have a great day!

Are you sure you want to report abuse against this website?

Please note that your query will be processed only if we find it relevant. Rest all requests will be ignored. If you need help with the website, please login to your dashboard and connect to support

Description:

Terms & conditions:

phytochoice

EPIPEN

MDMA (Molly) 50 mg

EQ300

Aromasin25mg

NICK TRIGILI GYM

Select a date and time slot to book an Appointment

Safety and Abuse Reporting

Thanks for being awesome!

Are you sure you want to report abuse against this website?

RAVICTI

Description:

Terms & conditions:

Share Via:

Related Products

phytochoice

EPIPEN

MDMA (Molly) 50 mg

EQ300

Aromasin25mg

Subscribe to our newsletter and stay in touch

Safety and Abuse Reporting

Thanks for being awesome!

Are you sure you want to report abuse against this website?